Martin Brenner - Aug 29, 2022 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
Chief Scientific Officer
Signature
/s/ Martin Brenner
Stock symbol
IBIO
Transactions as of
Aug 29, 2022
Transactions value $
$0
Form type
4
Date filed
8/31/2022, 04:00 PM
Previous filing
Aug 25, 2021
Next filing
Nov 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBIO Stock Option (right to buy) Award $0 +700K $0.00 700K Aug 29, 2022 Common Stock 700K $0.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.